OCS
OCS clinical trials: Oculis Holding AG
Every trial on ClinicalTrials.gov where Oculis Holding AG is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 11
- Trials linked
- 10
- As lead sponsor
- 1
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
OCS on the catalyst calendar · OCS registry changes
- Primary completion Dec 2026Sponsor estimatePhase 2/Phase 3NCT07548632A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseOculis · Dry Eye Disease (DED)Active, not recruitingOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 3NCT07623668Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchOculis · Optic NeuritisRecruitingOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2, 2024ActualPhase 3NCT06128369A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular...Oculis · Inflammation Eye PainTerminatedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2, 2026ActualPhase 3NCT06172257A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)Oculis · Diabetic Macular EdemaCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 10, 2026ActualPhase 2/Phase 3NCT05066997A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)Oculis · Diabetic Macular EdemaCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 16, 2024ActualPhase 2NCT04762017OCS-05 in Patients With Optic NeuritisOculis · Optic NeuritisCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2020ActualPhase 2NCT04130802OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsOculis · Inflammation CornealCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 27, 2024ActualPhase 2NCT05896670Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseOculis · Dry Eye DiseaseCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 22, 2023ActualPhase 3NCT05147233A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and...Oculis · Inflammation Eye PainCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 28, 2019ActualPhase 2NCT05343156Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular EdemaOculis · Diabetic Macular EdemaCompletedOCSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimatePhase 2NCT05608837Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular EdemaQuan Dong Nguyen · Uveitis Related Cystoid Macular EdemaActive, not recruitingOCSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 11 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner